EncrypGen Bond STO Concludes Successfully

POMPANO BEACH, Fla. - March 24, 2021 - PRLog -- This week, Encrypgen's bond sale STO concluded with a total of about $200,000 USD raised. The sale was hosted on CoinMetro's Ignium platform. The purpose of the sale was to help EncrypGen to jumpstart its user base.  There are 50,000,000 potential users of the Gene-Chain, those who have done genetic testing through the big testing companies. Money raised will help EncrypGen acquire users from among that demographic.

So far, 7020 people have created Gene-Chain accounts and have received $DNA wallets on it. $DNA is how people are paid for their genomic data, it is a widely-available cryptocurrency. EncrypGen will target more users through partnerships like that just entered into with IndyGenus.ai and existing partnerships like that with DigiPharm and others, and through advertising wisely using the funds raised in the bond sale STO in order to get more Gene-Chain users uploading files.

CEO Dr. Koepsell stated "this past year saw Wall Street make significant moves to monopolize genomic data, through a 4.7 billion dollar purchase of ancestry.com and an upcoming SPAC for about the same amount for 23andMe. Our platform is the democratic, decentralized alternative. It is the only such alternative marketplace, built to distribute most of the wealth in our genes to those who contribute their data. We think it is ethical, scientifically necessary, and a huge distruption in the genomics data field. We will continue to get the news out, to make people aware of both the value of their genetic data, and the ability to make money from it using the Gene-Chain."

EncrypGen now is crafting a public relations and direct marketing campaign to use the funds raised to acquire users and grow the Gene-Chain, making it scientifically viable and revenue-generating.